Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

28.800
+0.0600.21%
Volume:6.40M
Turnover:186.59M
Market Cap:10.20B
PE:-32.36
High:29.960
Open:29.620
Low:28.540
Close:28.740
52wk High:58.450
52wk Low:22.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:2.55
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.890
ROE:-1.18%
ROA:-1.06%
PB:1.67
PE(LYR):-32.36
PS:3.62

Loading ...

Everest Medicines - Agreement With Dimerix to Develop & Commercialize Dmx-200 in Greater China, South Korea and Southeast Asia

THOMSON REUTERS
·
Jun 16

Everest Medicines - Deal Includes $10 Mln Upfront, up to $30 Mln Development Milestones, $300 Mln Sales Milestones, 10%-15% Royalties

THOMSON REUTERS
·
Jun 16

Everest Medicines - Dmx-200 Receives Orphan Drug Designations From FDA and Ema

THOMSON REUTERS
·
Jun 16

Everest Medicines licenses Dimerix’s DMX-200 rights for Greater China, South Korea and Southeast Asia in deal worth up to USD 340 million

Reuters
·
Jun 16

Everest Medicines (SEHK:1952) Stock Valuation After New Ophthalmology And Cardiovascular Licensing Deals

Simply Wall St.
·
Jun 15

Everest Medicines Expands Partnerships To Broaden Pipeline And Future Cash Flows

Simply Wall St.
·
Jun 12

Changan Huitong-backed Maike Aote clears HKEX main board listing hearing

Reuters
·
Jun 11

EVEREST MED Receives 'Buy' Rating from Bank of Communications International, Highlighting Strong Overseas Development Potential

Stock News
·
Jun 10

Everest Medicines' Substantial Shareholder Boosts Stake

MT Newswires Live
·
Jun 10

Everest Medicines Says CBC Group Purchases 679,000 Shares For Hk$18.9 Million On June 8-9

Reuters
·
Jun 10

CICC Maintains Outperform Rating on Everest Med with HK$41.5 Target Price

Stock News
·
Jun 10

EVEREST MED's Principal Shareholder Fu Wei Increases Stake by 679,000 Shares

Stock News
·
Jun 10

EVEREST MED: CBC Group and Honorary Chairman Wei Fu Add 679,000 Shares for HK$18.90 Million

Bulletin Express
·
Jun 10

Everest Medicines - Cbc Group Purchases 679,000 Shares for HK$18.9 Mln at HK$27.9 per Share June 8-9, 2026

THOMSON REUTERS
·
Jun 10

Everest Med Expands into Presbyopia Consumer Healthcare with Acquisition of LNZ100 Rights for Greater China

Deep News
·
Jun 09

EVEREST MED Chairman Boosts Stake with 20,000 Share Purchase at HK$28.8 Each

Deep News
·
Jun 08

EVEREST MED Secures Exclusive Rights for LNZ100 in Greater China from Jixing

Stock News
·
Jun 08

Everest Med inks exclusive Greater China deal with Corxel for FDA-approved presbyopia therapy LNZ100

Bulletin Express
·
Jun 08

Everest Medicines - to Pay Upfront, Milestone Payments and Tiered Royalties for Lnz100

THOMSON REUTERS
·
Jun 08

Everest Medicines - Enters Agreement for Exclusive Lnz100 License in Greater China

THOMSON REUTERS
·
Jun 08